Rhodes Kevin H sold $1.3M of MMM

3M (MMM) will contest Australia's A$2B ($1.38B) lawsuit over PFAS contamination from its firefighting foam, arguing the legal claim is unsustainable under Australian law. The case centers on public nuisance allegations related to environmental damage.

JPMorgan reduced its price target for 3M (MMM) from $205 to $185. Separately, Deutsche Bank adjusted its target to $194 from $192, maintaining a Hold rating. 3M's stock is currently at $163.58, up 0.34% year-to-date.

Bernstein upgraded 3M (MMM) from Underperform to Market Perform, raising its price target to $171. Analyst Varun Govindaraj cited improved R&D strategy, AI-driven recovery, and lower PFAS legal risk. However, Bernstein sees limited upside due to recent stock gains and ongoing legal uncertainties. 3M's forward P/E is 21.92x, and its debt stands at $13.16 billion.

Analysts cover five stocks: Genius Sports (GENI) with a $8 target, CF Industries (CF) with a $162 target, 3M (MMM) upgraded to Hold with a $171 target, Nike (NKE) downgraded to Sell with a $30 target, and Synopsys (SNPS) upgraded to Buy with a $700 target. Analysts cite growth, valuation, and market conditions as key factors.

3M (NYSE:MMM) CEO William Brown reported that the company's operational turnaround is ahead of schedule, with improved margins, delivery performance, and new product launches. However, ongoing PFAS litigation, including a recent class action and a lawsuit by the Australian government, presents continued legal risks. 3M expects 20% of sales from new products by 2027 and is tracking above a 25% operating margin by that year.

A federal judge ruled that 3M, DuPont, Honeywell, and others must face a lawsuit from Connecticut firefighters over toxic 'forever chemicals' in protective gear. The plaintiffs allege the chemicals increased cancer risk. The judge found the unions had standing to seek damages. PFAS, including 3M's Scotchlite and DuPont's Kevlar, were named. The lawsuit began in June 2024.